In their recent debt to equity, they set a minimum conversion price of 0.002. Which means the company thinks the share price could go there and to 0.001, otherwise why bother setting this floor?
Ann: Halucenex Phase II Clinical Trial Update, page-13
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ME1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.1¢ |
Change
-0.007(38.2%) |
Mkt cap ! $1.983M | |||
| Open | High | Low | Value | Volume |
| 1.6¢ | 1.6¢ | 1.1¢ | $165.0K | 12.24M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 22 | 5129731 | 1.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.1¢ | 375860 | 5 |
View Market Depth
| Last trade - 13.40pm 20/06/2024 (20 minute delay) ? |
| ME1 (ASX) Chart |